Dashboard
Manage Tickers

NVS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novartis-announces-plans-to-build-flagship-manufacturing-hub-in-north-carolina
Novartis Announces Plans To Build Flagship...
11/19/2025 17:34:22

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 203...

Core News & Articles
Competition Bureau Expands Its Investigati...
11/19/2025 17:17:40

https://www.canada.ca/en/competition-bureau/news/2025/11/competition-bureau-expands-its-investigation-into-bwx-technologies-acq...

is-the-market-bullish-or-bearish-on-novartis-ag
Is the Market Bullish or Bearish on Novart...
11/18/2025 16:00:46

is-ai-the-key-to-beating-cancer-why-pharma-stocks-are-soaring
Is AI The Key To Beating Cancer? Why Pharm...
11/17/2025 20:52:18

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

trump-unveils-200-billion-trade-deal-with-switzerland-and-liechtenstein-to-cull-385-billion-us-goods-deficit-by-2028
Trump Unveils $200 Billion Trade Deal With...
11/15/2025 07:05:38

President Donald Trump announced a framework for a trade deal with Switzerland and Liechtenstein on Friday.

novartis-investigational-medicine-shows-potent-activity-against-drug-resistant-malaria-strains
Novartis' Investigational Medicine Shows P...
11/13/2025 17:33:20

Novartis' GanLum met key Phase 3 goals, showing strong efficacy and safety in malaria patients, including against resistant...

novartis-opens-new-production-site-in-carlsbad-california
Novartis Opens New Production Site In Carl...
11/10/2025 14:32:13

Novartis, a leading global innovative medicines company, today announced the opening of a new 10,000-square-foot radioligand th...

terns-pharmaceuticals-leukemia-drug-seen-as-potential-disruptor-in-cml-treatment-landscape-analyst-upgrades
Terns Pharmaceuticals' Leukemia Drug Seen ...
11/03/2025 18:05:11

Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the sto...

trump-offers-help-to-dilbert-creators-cancer-fight
Trump Offers Help To 'Dilbert' Creator's C...
11/03/2025 09:32:45

Trump offers help to cancer-stricken Dilbert creator Scott Adams after he appeals for assistance on social media. Adams seeks a...

novartis-ianalumab-first-drug-to-reduce-disease-activity-and-patient-burden-in-sjgrens-disease-phase-iii-trials
Novartis Ianalumab First Drug To Reduce Di...
10/29/2025 14:40:37

https://www.globenewswire.com/news-release/2025/10/29/3176619/0/en/Novartis-ianalumab-first-drug-to-reduce-disease-activity-and...

is-the-market-bullish-or-bearish-on-novartis-ag
Is the Market Bullish or Bearish on Novart...
10/29/2025 14:00:51

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

novartis-maintains-outlook-even-as-generics-bite-into-profits
Novartis Maintains Outlook Even As Generic...
10/28/2025 10:58:47

Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighe...

merger-monday-makes-comeback-as-us-ma-tops-80-billion-in-24-hours
'Merger Monday' Makes Comeback As US M&A T...
10/28/2025 09:44:49

U.S. companies have struck more than $80 billion worth of deals in the past 24 hours, in the latest sign that mergers and acqui...

novartis-reaffirmed-its-full-year-2025-guidance-maintaining-expectations-for-high-single-digit-sales-growth-and-low-teens-core-operating-income-growth
Novartis Reaffirmed Its Full-Year 2025 Gui...
10/28/2025 07:03:00

novartis-q3-adj-eps-225-inline-sales-13909b-miss-14105b-estimate
Novartis Q3 Adj. EPS $2.25, Inline, Sales ...
10/28/2025 06:56:36

Novartis (NYSE:NVS) reported quarterly earnings of $2.25 per share which met the analyst consensus estimate. This is a 9.22 per...

avidity-biosciences-soars-after-72-per-share-novartis-takeover
Avidity Biosciences Soars After $72 Per Sh...
10/27/2025 18:52:41

Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.

what-to-expect-from-novartiss-earnings
What to Expect from Novartis's Earnings
10/27/2025 14:02:47

avidity-shareholders-win-big-as-novartis-moves-fast-on-12-billion-deal
Avidity Shareholders Win Big As Novartis M...
10/27/2025 10:11:40

Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash.

stock-market-today-nasdaq-dow-jones-sp-500-futures-climb-ahead-of-busy-week-on-wall-streetnovartis-nucor-waste-management-in-focus-updated
Stock Market Today: Nasdaq, Dow Jones, S&P...
10/27/2025 10:02:00

Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION